Lumanity Executive and Leadership Team

Christopher Evans, the President Patient-Centered Outcomes at Lumanity, directs the integration of patient perspectives into clinical development and commercialization strategies. Evans oversees the generation of real-world evidence that demonstrates product value to payers and regulators across North America and Europe. By architecting frameworks that capture patient-reported outcomes, the President Patient-Centered Outcomes ensures that medical advances align with actual patient needs and quality-of-life metrics. This leadership role involves collaborating with biotech partners to refine evidence-based narratives that support sustainable market access. Christopher Evans drives the development of methodologies that quantify the impact of treatments, ultimately empowering providers to make informed clinical decisions. Through rigorous data analysis and strategic planning, the President Patient-Centered Outcomes secures the necessary evidence to validate product efficacy in diverse global markets, ensuring that therapeutic innovations reach patients efficiently while reflecting true value.

John Howley, the President, Communications (US) at Lumanity, manages the strategic messaging and product narrative development for pharmaceutical clients operating within the United States market. Howley directs cross-functional teams to translate complex scientific data into compelling, stakeholder-relevant communications that support successful brand launches. The President, Communications (US) oversees the alignment of commercial messaging with regulatory requirements, ensuring that product value propositions resonate with providers and payers alike. By optimizing communication channels and digital engagement strategies, Howley drives market awareness and product adoption. This leadership role involves close coordination with global commercial teams to maintain brand consistency while addressing specific regional market nuances. John Howley executes high-impact campaigns that position medical products for long-term success, leveraging deep industry expertise to navigate the competitive landscape and deliver clear, evidence-backed narratives that facilitate timely and decisive action across the healthcare ecosystem.

Julie Munakata, the Global President, HEOR at Lumanity, architects the health economics and outcomes research strategies that underpin global commercialization efforts. Munakata oversees the design and execution of economic models that demonstrate the cost-effectiveness of medical interventions for international regulatory bodies and payers. The Global President, HEOR drives the synthesis of clinical data into robust evidence packages, enabling pharmaceutical companies to secure favorable reimbursement and market access. By managing large-scale research initiatives across Asia, Europe, and North America, Munakata ensures that product value is quantified and communicated effectively. This leadership role involves advising the Board on emerging market trends and regulatory shifts that impact pricing and access. Julie Munakata executes strategies that bridge the gap between scientific innovation and commercial viability, ensuring that medical advances are accessible to patients at prices reflective of their clinical and economic value in the global healthcare market.

Marissa Poli, the President at Lumanity, directs the overarching operational strategy and business development initiatives that support the company's mission of accelerating medical access. Poli oversees the integration of commercial and regulatory affairs to ensure that client projects achieve transformative outcomes in competitive global markets. The President drives organizational efficiency by aligning internal resources with the complex needs of top-tier pharmaceutical and biotech partners. This leadership role involves fostering cross-departmental collaboration to deliver successful development strategies and product campaigns. By focusing on sustainable growth and market expansion, Poli ensures that the company maintains its position as a leader in real-world evidence and commercialization. Marissa Poli executes high-level strategic decisions that empower providers and regulators to take timely action, ultimately turning medical aspirations into reality through precise, data-driven commercialization frameworks that span over 50 countries and multiple therapeutic areas.

Stephen Weisman, the Global President at Lumanity, manages the international operational footprint and strategic direction of the firm across North America, the United Kingdom, Europe, and Asia. Weisman directs the expansion of service offerings, ensuring that the company provides comprehensive support for medical, commercial, and regulatory affairs. The Global President oversees the alignment of regional teams with the broader corporate mission to optimize access to medical advances. By fostering partnerships with global biotech leaders, Weisman drives the implementation of strategies that facilitate successful product launches and sustainable market positioning. This leadership role involves managing complex stakeholder relationships and ensuring that all work conducted in over 50 countries meets the highest standards of evidence generation and commercial insight. Stephen Weisman executes initiatives that enhance the company's ability to translate science into real-world value, ultimately supporting the delivery of innovative treatments to patients worldwide.

Robert Budreau, the President & Producer at Lumanity, directs the creative production and strategic content development functions that support commercial brand launches and product campaigns. Budreau oversees the transformation of complex scientific data into engaging, high-impact visual and narrative assets that resonate with diverse global stakeholders. The President & Producer drives the creative vision for product narratives, ensuring that every campaign effectively communicates the value of medical advances to providers, payers, and patients. By managing the intersection of creative storytelling and rigorous evidence-based research, Budreau ensures that commercial messaging remains both compelling and scientifically accurate. This leadership role involves coordinating with commercial teams to align production timelines with market launch schedules. Robert Budreau executes innovative content strategies that position products for success, leveraging deep expertise in media and communication to amplify the impact of medical innovations in the global healthcare marketplace.